HERTFORDSHIRE, England and PITTSBURGH, Feb. 3, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it will host an Investor Day on March 1, 2017 in New York City. Mylan CEO Heather Bresch and the company's senior leadership team will present the company's financial guidance for 2017 and an overview of the company's strategic vision and growth strategy for 2017 and beyond.
The presentations will be broadcast live via webcast beginning at 1:00 p.m. ET. The meeting is expected to conclude by 5:00 p.m. ET. In-person attendance is by invitation only.
The company intends to issue its financial results for the fourth quarter and year ended December 31, 2016 on March 1, in conjunction with Investor Day.
To access the live webcast and view the accompanying slide presentations, visit the Investor Relations section of Mylan's website, at http://investor.mylan.com, at least 15 minutes before the presentation is scheduled to begin to register and download or install any necessary software. If you are unable to view the live webcast, a replay will be available after the event's conclusion for a limited period of time. In addition to the webcast, U.S. callers can access the event, in listen-only mode, at 877.877.1275 or 412.902.6542 for international callers.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 2,700 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS worldwide depend. We market our products in more than 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-to-host-investor-day-on-march-1-2017-in-new-york-city-300401851.html
SOURCE Mylan N.V.